$RCEL News
Last published 3d ago
- 3d agoRCELAVITA Medical to Host Investor Webinar BriefingGlobeNewswireAVITA Medical to Host Investor Webinar Briefing...
- 3d agoRCELAVITA Medical to Host Investor Webinar BriefingGlobeNewswireVALENCIA, Calif., Nov. 08, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)) ("AVITA Medical," or the "Company"), a leading therapeutic acute wound care company delivering
- 6d agoRCELAVITA Medical, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 6d agoRCELAVITA Medical Reports Third Quarter ResultsGlobeNewswireDelivers Strong Q3 With 53% Year-Over-Year Revenue Growth Raises Full Year 2026 Revenue Guidance VALENCIA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading
- 6d agoRCELAVITA Medical Reports Third Quarter ResultsGlobeNewswireAVITA Medical Reports Third Quarter Results: Delivers Strong Q3 With 53% Year-Over-Year Revenue Growth; Raises Full Year 2026 Revenue Guidance ...
- 6d agoRCELAVITA Medical Announces National Medicare Physician Payment Framework and Simplified Billing Codes for RECELL Procedures in 2027GlobeNewswireCMS finalizes nationally published physician valuations; CMS’s four-code structure simplifies procedure reporting beginning January 1, 2027 VALENCIA, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc.
- 3w agoRCELAVITA Medical to Announce Third Quarter 2026 Financial ResultsGlobeNewswireVALENCIA, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)) ("AVITA Medical," or the "Company"), a leading therapeutic acute wound care company delivering
- 1mo agoRCELEvolving Landscape of Temporary Wound Coverage: Clinical Evidence and Experience with PermeaDerm® - AVITA MEDICAL INCEarnings Call TranscriptsGood afternoon and welcome to today's webinar, The Evolving Landscape of Temporary Wound Coverage, Clinical Evidence, and Experience with Permiaderm. Today's discussion will explore the evolving role of temporary wound c
- 1mo agoRCELMorgan Stanley 24th Annual Global Healthcare Conference - AVITA MEDICAL INCEarnings Call TranscriptsAll right, perfect. Thank you, everybody. I'd like to welcome the Evita medical team to the stage today, and thanks again for joining us. It's been a few years since we've had you guys do this, and it's always great to g
- 1mo agoRCELMorgan Stanley 24th Annual Global Healthcare Conference - AVITA MEDICAL INCEarnings Call TranscriptsAll right, perfect. Thank you, everybody. I'd like to welcome the Evita medical team to the stage today, and thanks again for joining us. It's been a few years since we've had you guys do this, and it's always great to g
- 1mo agoRCELMorgan Stanley 24th Annual Global Healthcare Conference - AVITA MEDICAL INCEarnings Call TranscriptsAll right, perfect. Thank you, everybody. I'd like to welcome the Evita medical team to the stage today, and thanks again for joining us. It's been a few years since we've had you guys do this, and it's always great to g
- 2mo agoRCELAVITA Medical to Participate in Lake Street Best Ideas Growth Conference and Morgan Stanley Healthcare ConferenceGlobeNewswireVALENCIA, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company delivering transformative solutions, today announced that its senior
- 2mo agoRCELAVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical OutcomesGlobeNewswirePrimary endpoint achieved, demonstrating a 70% economic advantage over allograft based on product cost per percent total body surface area treated (p<0.001) 96% reduction in preparation time and comparable clinical
- 3mo agoRCELCG 46TH ANNUAL GROWTH CONFERENCE - AVITA MEDICAL INCEarnings Call TranscriptsGood morning, everyone. Thanks for joining for another day for the Canaccord 46th Annual Boston Growth Conference. This morning, we're joined by Kerry Vance, who's the CEO of Aveda Medical. Kerry, I'm really pleased to h
- 3mo agoRCELCG 46TH ANNUAL GROWTH CONFERENCE - AVITA MEDICAL INCEarnings Call TranscriptsGood morning, everyone. Thanks for joining for another day for the Canaccord 46th Annual Boston Growth Conference. This morning, we're joined by Kerry Vance, who's the CEO of Aveda Medical. Kerry, I'm really pleased to h
- 3mo agoRCELAVITA Medical to Host Investor Webinar BriefingGlobeNewswireVALENCIA, Calif., Aug. 09, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and
- 3mo agoRCELAVITA Medical Announces Participation at Canaccord Genuity Growth ConferenceGlobeNewswireVALENCIA, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company delivering transformative solutions, today announced it will
- 3mo agoRCELAVITA Medical Reports Second Quarter Results, Raises 2026 Revenue Guidance, and Expects Fourth Quarter Cash Flow BreakevenGlobeNewswireVALENCIA, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company delivering transformative solutions ("AVITA Medical," or the
- 3mo agoRCELFASTER GRAFT READINESS: EMERGING INNOVATIONS IN WOUND BED PREPARATION AND BURN RECONSTRUCTION - AVITA MEDICAL INCEarnings Call TranscriptsWelcome, everyone. My name is Maureen Kiley. I'm the Senior Director of the American Burn Association, and I'm proud to welcome the Avita Medical Team here with Karen Nguyen and Dr. Bell. This is the first in a series of
- 4mo agoRCELAVITA Medical to Announce Second Quarter 2026 Financial ResultsGlobeNewswireVALENCIA, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)) ("AVITA Medical," or the "Company"), a leading therapeutic acute wound care company delivering
- 4mo agoRCELAVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual MeetingGlobeNewswireFirst U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patientsFindings presented at the British Burn Association Annual Meeting support the role of RECELL GO in
- 5mo agoRCELAVITA Medical to Host Investor Webinar BriefingGlobeNewswireVALENCIA, Calif., May 17, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective
- 6mo agoRCELAVITA Medical Reports First Quarter 2026 Financial ResultsGlobeNewswireVALENCIA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company delivering transformative solutions ("AVITA Medical," or the
- 6mo agoRCELAVITA Medical Names Cary Vance as Chief Executive OfficerGlobeNewswireBoard appoints Cary Vance as President and Chief Executive Officer Follows successful interim tenure and thorough search process by the Board Jan Stern Reed elected as Chair of the AVITA Medical Board VALENCIA, Calif.,
- 6mo agoRCELAVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GOGlobeNewswireRECELL GO® receives regulatory clearance in Australia and New Zealand, enabling commercialization across both marketsRECELL GO is AVITA Medical's next-generation system that automates and standardizes the
- 6mo agoRCELAVITA Medical to Announce First Quarter 2026 Financial ResultsGlobeNewswireVALENCIA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company, today announced that it will report its first quarter 2026
- 7mo agoRCELAVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn AssociationGlobeNewswireRecognition highlights pioneering contributions to modern burn care including development of RECELL® Spray-On Skin™ VALENCIA, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc.
- 7mo agoRCELAVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin GraftingGlobeNewswireMean time to graft reduced to 13.6 days vs. 33.2 days real-world benchmark (~20 day reduction)Median time to graft of 11 days, with grafting as early as 5 daysStudy ongoing with full dataset expected in 2026Management to
- 7mo agoRCELAVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency PreparednessGlobeNewswireAgreement ensures rapid nationwide access to RECELL® for burn mass casualty incidents, providing BARDA access to 3,000 units any time over the 10-year contract VALENCIA, Calif., April 08, 2026 (GLOBE NEWSWIRE) --
- 7mo agoRCELAVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx DataGlobeNewswireCohealyx® multi-center study interim analysis and new case data to be presentedRECELL® and PermeaDerm® data reinforce a comprehensive approach to wound healingEvidence demonstrates potential to improve
- 8mo agoRCELAVITA Medical to participate at the TD Cowen 46th Annual Health Care ConferenceGlobeNewswireVALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced Cary Vance,
- 9mo agoRCELAVITA Medical to Host Investor Webinar BriefingGlobeNewswireVALENCIA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective
- 9mo agoRCELAVITA Medical Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswireVALENCIA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company delivering transformative solutions ("AVITA Medical," or the
- 9mo agoRCELData at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologiesGlobeNewswireFirst surgeon-reported case using RECELL®, PermeaDerm®, and Cohealyx™ together in a single care pathwayNew clinical and tissue-level data on PermeaDerm and Cohealyx highlight wound bed preparation and
- 10mo agoRCELAVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth OutlookGlobeNewswireVALENCIA, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced unaudited
- 10mo agoRCELAVITA Medical Announces Changes to its Board of DirectorsGlobeNewswireVeteran healthcare executive Joe Woody joins the BoardLou Panaccio retires after over a decade of service VALENCIA, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. ((ASX: AVH, NASDAQ:RCEL), a
- 10mo agoRCELAVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireVALENCIA, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that Cary
- 11mo agoRCELAVITA Medical to Present at the Piper Sandler 37ᵗʰ Annual Healthcare ConferenceGlobeNewswireVALENCIA, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that the Company
- 1y agoRCELAVITA Medical to Host Investor Webinar BriefingGlobeNewswireVALENCIA, Calif., Nov. 09, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective
- 1y agoRCELData Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound TreatmentGlobeNewswireVALENCIA, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)) ("AVITA Medical," or the "Company"), a leading therapeutic acute wound care company, today announced two podium
- 1y agoRCELAVITA Medical to Announce Third Quarter 2025 Financial ResultsGlobeNewswireVALENCIA, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)) ("AVITA Medical," or the "Company"), a leading therapeutic acute wound care company delivering transformative solutions,
- 1y agoRCELAVITA Medical Welcomes Support for RECELL® in Burns in AustraliaGlobeNewswireAustralia's Medical Services Advisory Committee (MSAC) recognizes RECELL® as safe and effective, with benefits in healing, donor site sparing, and reduced hospital stays VALENCIA, Calif., Oct. 28, 2025 (GLOBE
- 1y agoRCELAVITA Medical Announces CEO TransitionGlobeNewswireBoard Chairman Cary Vance appointed Interim CEOBoard member Jan Stern Reed appointed Lead Independent DirectorThird quarter 2025 preliminary revenue expected to be approximately $17 million VALENCIA, Calif., Oct. 16,
- 1y agoRCELCMS New Technology Add-On Payment Expands Access to RECELL® for Patients with Non-Burn Acute WoundsGlobeNewswireHospitals may receive up to $4,875 in added reimbursement when using RECELL to treat non-burn full-thickness acute wounds resulting from trauma or surgery Effective October 1, the add-on payment eases financial
- 1y agoRCELAVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across EuropeGlobeNewswireVALENCIA, Calif., Sept. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)) ("AVITA Medical", or the "Company"), a leading therapeutic acute wound care company, today announced it has received the
- 1y agoRCELRCEL Alert: Kirby McInerney LLP Encourages AVITA Medical, Inc. Investors to Inquire about InvestigationBusiness WireThe law firm of Kirby McInerney LLP reminds investors its investigation on behalf of AVITA Medical, Inc. ("AVITA" or the "Company") (NASDAQ:RCEL) investors concerning the Company's possible violation of the federal
- 1y agoRCELAVITA Medical, Inc. (RCEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Earnings Call Transcripts
- 1y agoRCELReal-World Data Shows Significant Reduction in Hospital Stay Using AVITA Medical's RECELL® SystemGlobeNewswireAnalysis of U.S. national burn registry data demonstrates 36% shorter hospital stays in adults with deep second-degree burns treated with RECELL versus traditional skin graftingMore than $42,000 per patient cost savings,
- 1y agoRCELKirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of InvestorsGlobeNewswireNEW YORK, Aug. 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against AVITA Medical, Inc. ("AVITA" or the "Company") (NASDAQ:RCEL). The investigation concerns whether
- 1y agoRCELAVITA Medical Announces September Investor Conference ParticipationGlobeNewswireVALENCIA, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. ((ASX: AVH, NASDAQ:RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that senior